
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
What are the Pharmacological Differences Between Angiotensin II Antagonists
Author(s)Thomas Unger, MD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 27 years ago
New Drug Class Offers Benefits in Heart Failureover 27 years ago
Exploring the Benefits Beyond Blood Pressure ControlNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
4
Medical School Diversity Declines Following Affirmative Action Repeal
5